Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 20.00
0.00 (0.00%)
May 21, 2026, 12:09 PM CST
Neith Market Cap
Neith has a market cap or net worth of 833.08 million as of May 29, 2026. Its market cap has decreased by -29.82% in one year.
Market Cap
833.08M
Enterprise Value
698.53M
Revenue
32.03M
Ranking
n/a
PE Ratio
1,753.85
Stock Price
20.00
Market Cap Chart
Since November 3, 2004, Neith's market cap has increased from 483.77M to 833.08M, an increase of 72.21%. That is a compound annual growth rate of 2.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 833.08M | -7.19% |
| Dec 30, 2025 | 897.64M | -27.93% |
| Dec 27, 2024 | 1.25B | -13.21% |
| Dec 29, 2023 | 1.43B | 166.67% |
| Dec 30, 2022 | 538.12M | 47.83% |
| Dec 30, 2021 | 364.02M | 7.98% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Level Biotechnology | 1.09B |
| Holy Stone Healthcare | 1.06B |
| Lukas Biomedical | 1.05B |
| GeneReach Biotechnology | 1.02B |
| U-Neuron Biomedical | 1.00B |
| TCI GENE | 976.32M |
| Taiwan Advance Bio-Pharmaceutical | 896.40M |
| NatureWise Biotech & Medicals | 895.40M |